MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 4.55 HKD 1.11% Market Closed
Market Cap: 1.9B HKD
Have any thoughts about
MicroTech Medical Hangzhou Co Ltd?
Write Note

MicroTech Medical Hangzhou Co Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MicroTech Medical Hangzhou Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Total Current Liabilities
ÂĄ93.4m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Current Liabilities
ÂĄ588.2m
CAGR 3-Years
75%
CAGR 5-Years
65%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Current Liabilities
ÂĄ2.9B
CAGR 3-Years
11%
CAGR 5-Years
23%
CAGR 10-Years
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Current Liabilities
ÂĄ12.9B
CAGR 3-Years
18%
CAGR 5-Years
21%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Total Current Liabilities
ÂĄ1B
CAGR 3-Years
52%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Current Liabilities
ÂĄ5.8B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MicroTech Medical Hangzhou Co Ltd
Glance View

Market Cap
1.9B HKD
Industry
Health Care

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.

Intrinsic Value
5.84 HKD
Undervaluation 22%
Intrinsic Value
Price

See Also

What is MicroTech Medical Hangzhou Co Ltd's Total Current Liabilities?
Total Current Liabilities
93.4m CNY

Based on the financial report for Dec 31, 2023, MicroTech Medical Hangzhou Co Ltd's Total Current Liabilities amounts to 93.4m CNY.

What is MicroTech Medical Hangzhou Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
24%

Over the last year, the Total Current Liabilities growth was 18%. The average annual Total Current Liabilities growth rates for MicroTech Medical Hangzhou Co Ltd have been 24% over the past three years .

Back to Top